BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34844822)

  • 1. Recombinant Bacillus subtilis flagellin Hag is a potent immunostimulant with reduced proinflammatory properties compared to Salmonella enterica serovar Typhimurium FljB.
    Côté-Cyr M; Gauthier L; Zottig X; Bourgault S; Archambault D
    Vaccine; 2022 Jan; 40(1):11-17. PubMed ID: 34844822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of host immune responses by oral vaccination to Salmonella enterica serovar Typhimurium harboring both FliC and FljB flagella.
    Eom JS; Seok Kim J; Im Jang J; Kim BH; Young Yoo S; Hyeon Choi J; Bang IS; Lee IS; Keun Park Y
    PLoS One; 2013; 8(9):e74850. PubMed ID: 24069357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant flagellins with deletions in domains D1, D2, and D3: Characterization as novel immunoadjuvants.
    Biedma ME; Cayet D; Tabareau J; Rossi AH; Ivičak-Kocjan K; Moreno G; Errea A; Soulard D; Parisi G; Jerala R; Berguer P; Rumbo M; Sirard JC
    Vaccine; 2019 Jan; 37(4):652-663. PubMed ID: 30583910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice.
    Xiao XX; Zhang Y; Liu JX; Wei QL; Yin XP
    Arch Virol; 2016 Mar; 161(3):685-91. PubMed ID: 26650039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar Typhimurium to potentiate mucosal and systemic responses.
    Pino O; Martin M; Michalek SM
    Infect Immun; 2005 Oct; 73(10):6763-70. PubMed ID: 16177354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of NF-kappaB-dependent gene expression by Salmonella flagellins FliC and FljB.
    Simon R; Samuel CE
    Biochem Biophys Res Commun; 2007 Mar; 355(1):280-5. PubMed ID: 17292856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HA1-2-fljB Vaccine Induces Immune Responses against Pandemic Swine-Origin H1N1 Influenza Virus in Mice.
    Kang X; Yang Y; Jiao Y; Song H; Song L; Xiong D; Wu L; Pan Z; Jiao X
    J Mol Microbiol Biotechnol; 2016; 26(6):422-432. PubMed ID: 27721310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a monoclonal antibody directed against Salmonella enterica serovar Typhimurium and serovar [4,5,12:i:-].
    Rementeria A; Vivanco AB; Ramirez A; Hernando FL; Bikandi J; Herrera-León S; Echeita A; Garaizar J
    Appl Environ Microbiol; 2009 Mar; 75(5):1345-54. PubMed ID: 19124586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains.
    Sbrogio-Almeida ME; Mosca T; Massis LM; Abrahamsohn IA; Ferreira LC
    Infect Immun; 2004 May; 72(5):2546-55. PubMed ID: 15102762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease.
    Ghose C; Verhagen JM; Chen X; Yu J; Huang Y; Chenesseau O; Kelly CP; Ho DD
    Infect Immun; 2013 Jun; 81(6):2190-6. PubMed ID: 23545305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+-T-cell responses generated during murine Salmonella enterica serovar Typhimurium infection are directed towards multiple epitopes within the natural antigen FliC.
    Bergman MA; Cummings LA; Alaniz RC; Mayeda L; Fellnerova I; Cookson BT
    Infect Immun; 2005 Nov; 73(11):7226-35. PubMed ID: 16239517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface.
    Zhao Y; Li Z; Zhu X; Cao Y; Chen X
    Biomaterials; 2020 Aug; 249():120030. PubMed ID: 32315864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-flagellin antibody responses elicited in mice orally immunized with attenuated Salmonella enterica serovar Typhimurium vaccine strains.
    Massis LM; Braga CJ; Sbrogio-Almeida ME; Lauand C; Newton SM; Klebba PE; Ferreira LC
    Mem Inst Oswaldo Cruz; 2008 Sep; 103(6):606-10. PubMed ID: 18949334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and identification of H5 subtype avian influenza vaccine candidate based on flagellin].
    Wang J; Kang X; Jiao Y; Xiong D; Song L; Yang Y; Pan Z; Jiao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):117-20. PubMed ID: 24491047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive genetic variability linked to IS26 insertions in the fljB promoter region of atypical monophasic variants of Salmonella enterica serovar Typhimurium.
    Boland C; Bertrand S; Mattheus W; Dierick K; Jasson V; Rosseel T; Van Borm S; Mahillon J; Wattiau P
    Appl Environ Microbiol; 2015 May; 81(9):3169-75. PubMed ID: 25724958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FliC's Hypervariable D3 Domain Is Required for Robust Anti-Flagellin Primary Antibody Responses.
    López-Yglesias AH; Lu CC; Zhao X; Chou T; VandenBos T; Strong RK; Smith KD
    Immunohorizons; 2019 Sep; 3(9):422-432. PubMed ID: 31488506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flagellar phase variation of Salmonella enterica serovar Typhimurium contributes to virulence in the murine typhoid infection model but does not influence Salmonella-induced enteropathogenesis.
    Ikeda JS; Schmitt CK; Darnell SC; Watson PR; Bispham J; Wallis TS; Weinstein DL; Metcalf ES; Adams P; O'Connor CD; O'Brien AD
    Infect Immun; 2001 May; 69(5):3021-30. PubMed ID: 11292720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against Marinobacter algicola and Salmonella typhimurium flagellins do not cross-neutralize TLR5 activation.
    Terron-Exposito R; Dudognon B; Galindo I; Quetglas JI; Coll JM; Escribano JM; Gomez-Casado E
    PLoS One; 2012; 7(11):e48466. PubMed ID: 23155384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A porcine reproductive and respiratory syndrome virus (PRRSV) vaccine candidate based on the fusion protein of PRRSV glycoprotein 5 and the Toll-like Receptor-5 agonist Salmonella Typhimurium FljB.
    Xiong D; Song L; Zhai X; Geng S; Pan Z; Jiao X
    BMC Vet Res; 2015 May; 11():121. PubMed ID: 26001608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F18
    Won G; Lee JH
    Comp Immunol Microbiol Infect Dis; 2018 Jun; 58():44-51. PubMed ID: 30245050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.